Dyslipidemic effects of cigarette smoking on beta-blocker-induced serum lipid changes in systemic hypertension

This publication has 19 references indexed in Scilit:

• Influence of beta2 agonism and beta1 and beta2 antagonism on adverse effects and plasma lipoproteins: Results of a multicenter comparison of dilevalol and metoprolol
  The American Journal of Cardiology, 1989
• The effects of beta‐adrenergic blocking agents on blood lipid levels
  Clinical Cardiology, 1987
• Antihypertensive treatment and plasma lipoprotein levels: The associations in data from a population study
  The American Journal of Medicine, 1986
• Effect of beta blockers on blood lipid profile
  American Heart Journal, 1985
• Treatment of hypertension and its effect on cardiovascular risk factors: data from the Framingham Heart Study.
  Circulation, 1985
• Serum glucose levels during long-term observation of treated and untreated men with mild hypertension
  The American Journal of Medicine, 1984
• Effects of antihypertensive therapy on plasma lipids and lipoproteins in the multiple risk factor intervention trial
  The American Journal of Medicine, 1984
• Apolipoprotein A-I as a Marker of Angiographically Assessed Coronary-Artery Disease
  New England Journal of Medicine, 1983
• The combined effect of smoking and coffee drinking on LDL and HDL cholesterol.
  Circulation, 1979
• Beta-blockers and plasma triglycerides.
  BMJ, 1978